282 related articles for article (PubMed ID: 23262998)
21. Photodynamic antimicrobial chemotherapy in mice with Pseudomonas aeruginosa-infected wounds.
Zhao ZJ; Xu ZP; Ma YY; Ma JD; Hong G
PLoS One; 2020; 15(9):e0237851. PubMed ID: 32877414
[TBL] [Abstract][Full Text] [Related]
22. Blue laser light inhibits biofilm formation in vitro and in vivo by inducing oxidative stress.
Rupel K; Zupin L; Ottaviani G; Bertani I; Martinelli V; Porrelli D; Vodret S; Vuerich R; Passos da Silva D; Bussani R; Crovella S; Parsek M; Venturi V; Di Lenarda R; Biasotto M; Zacchigna S
NPJ Biofilms Microbiomes; 2019; 5(1):29. PubMed ID: 31602310
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds.
Björn C; Noppa L; Näslund Salomonsson E; Johansson AL; Nilsson E; Mahlapuu M; Håkansson J
Int J Antimicrob Agents; 2015 May; 45(5):519-24. PubMed ID: 25649371
[TBL] [Abstract][Full Text] [Related]
25. Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
Yoshida T; Yoshida S; Kobayashi M; Herndon DN; Suzuki F
J Leukoc Biol; 2010 Jan; 87(1):35-41. PubMed ID: 19843573
[TBL] [Abstract][Full Text] [Related]
26. Colistin-loaded silk membranes against wound infection with Pseudomonas aeruginosa.
Steinstraesser L; Trust G; Rittig A; Hirsch T; Kesting MR; Steinau HU; Jacobsen F
Plast Reconstr Surg; 2011 May; 127(5):1838-1846. PubMed ID: 21532413
[TBL] [Abstract][Full Text] [Related]
27. Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines-implications for delayed wound closure?
Trøstrup H; Lerche CJ; Christophersen LJ; Thomsen K; Jensen PØ; Hougen HP; Høiby N; Moser C
Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28645160
[TBL] [Abstract][Full Text] [Related]
28. Heparinase Is Essential for Pseudomonas aeruginosa Virulence during Thermal Injury and Infection.
Dzvova N; Colmer-Hamood JA; Griswold JA; Hamood AN
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061710
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
[TBL] [Abstract][Full Text] [Related]
30. Short Synthetic β-Sheet Antimicrobial Peptides for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Burn Wound Infections.
Zhong G; Cheng J; Liang ZC; Xu L; Lou W; Bao C; Ong ZY; Dong H; Yang YY; Fan W
Adv Healthc Mater; 2017 Apr; 6(7):. PubMed ID: 28135045
[TBL] [Abstract][Full Text] [Related]
31. Negative pressure wound therapy decreases mortality in a murine model of burn-wound sepsis involving Pseudomonas aeruginosa infection.
Liu Y; Zhou Q; Wang Y; Liu Z; Dong M; Wang Y; Li X; Hu D
PLoS One; 2014; 9(2):e90494. PubMed ID: 24587379
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies.
Zhu H; Kochevar IE; Behlau I; Zhao J; Wang F; Wang Y; Sun X; Hamblin MR; Dai T
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):586-593. PubMed ID: 28129422
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
34. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
[TBL] [Abstract][Full Text] [Related]
35. Application of
Lenzmeier TD; Mudaliar NS; Stanbro JA; Watters C; Ahmad A; Simons MP; Ventolini G; Zak JC; Colmer-Hamood JA; Hamood AN
J Med Microbiol; 2019 Oct; 68(10):1560-1572. PubMed ID: 31460863
[No Abstract] [Full Text] [Related]
36. Blue light treatment of Pseudomonas aeruginosa: Strong bactericidal activity, synergism with antibiotics and inactivation of virulence factors.
Fila G; Kawiak A; Grinholc MS
Virulence; 2017 Aug; 8(6):938-958. PubMed ID: 27763824
[TBL] [Abstract][Full Text] [Related]
37. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
38. The invasion of burned skin by Pseudomonas aeruginosa.
Carney SA; Dyster RE; Jones RJ
Br J Dermatol; 1973 Jun; 88(6):539-45. PubMed ID: 4197888
[No Abstract] [Full Text] [Related]
39. UVC light prophylaxis for cutaneous wound infections in mice.
Dai T; Garcia B; Murray CK; Vrahas MS; Hamblin MR
Antimicrob Agents Chemother; 2012 Jul; 56(7):3841-8. PubMed ID: 22564833
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of proliferation of Pseudomonas aeruginosa by KGF in an experimental burn model using human cultured keratinocytes.
Sobral CS; Gragnani A; Morgan J; Ferreira LM
Burns; 2007 Aug; 33(5):613-20. PubMed ID: 17418954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
